Pharma Journalist -

Allergan has completed the divestiture of its global generic pharmaceuticals business to Teva Pharmaceutical Industries. Allergan has received $33.4 billion in cash and 100.3 million…
Read More...

Ligand Pharmaceuticals Incorporated announces the signing of a license agreement for three programs utilizing Ligand’s LTP (Liver Targeting Prodrug) technology with Nucorion…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced that the European Medicines Agency (EMA) has granted PRIority MEdicines…
Read More...

Synaffix has completed a new set of preclinical studies that further supports the potential for its technology to enable safer and more effective targeted cancer therapeutics. The…
Read More...

DNAtrix, a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer, announced the successful intratumoral administration of DNX-2401 with the Alcyone…
Read More...

PeptiDream has entered into a Technology License Agreement with US-based Genentech, a member of the Roche Group, to non exclusively license its Peptide Discovery Platform System (PDPS)…
Read More...

Medidata announced that it has signed a multi-year enterprise deal with Hanmi Pharmaceutical, one of South Korea's leading drug makers. A Medidata customer since 2013, the …
Read More...

Oracle announced that after a detailed review and selection process, Pfizer has selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and…
Read More...

An innovative virtual reality smartphone app – A Walk Through Dementia – will launch at a three-day public installation at St Pancras International Station from 2 June. The…
Read More...

Delivra has entered into a technology licensing agreement with Kalytera Therapeutics. Based in California, Kalytera is a pharmaceutical company developing a portfolio of…
Read More...